文献速递脊柱关节炎

银屑病关节炎中肥胖与缓解或低疾病活动度可能性的关联:基于指数定义与患者定义缓解的横断面研究

Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study.
PubMed 文献 · RMD Open · 2023-01-01

该横断面研究纳入14个国家431例银屑病关节炎患者,其中肥胖136例(31.6%),评估肥胖与基于指数及患者定义的缓解/低疾病活动度的关联。肥胖患者达到VLDA、DAPSA缓解和MDA的调整OR分别为0.31、0.39和0.61,而DAPSA-LDA及患者自评缓解率两组相似。作者认为合并肥胖的银屑病关节炎患者按复合评分达到缓解/低疾病活动度的可能性较非肥胖者低2.5-3倍。

要点

  • 肥胖患者达到VLDA的调整OR为0.31(95%CI 0.13-0.77),达到DAPSA缓解的调整OR为0.39(95%CI 0.19-0.80)。
  • 肥胖患者达到MDA的调整OR为0.61(95%CI 0.38-0.99)。
  • DAPSA-LDA和患者自评缓解/低疾病活动度在肥胖与非肥胖患者中相似。

核心结论

  • 合并肥胖的银屑病关节炎患者按复合评分达到缓解/低疾病活动度的可能性较非肥胖患者低2.5-3倍,但基于患者自评的缓解/低疾病活动度率相似。
  • 合并肥胖的银屑病关节炎患者可能具有不同的疾病特征,需要个体化管理。

研究设计与样本

  • 研究使用ReFlaP国际多中心队列研究(NCT03119805)的数据,该研究连续纳入来自14个国家的确诊银屑病关节炎成人患者(病程≥2年)。
  • 研究为横断面研究,收集人口学、临床数据、合并症和患者报告结局,肥胖定义为医生报告和/或体重指数≥30 kg/m2。
  • 采用多变量回归模型评估肥胖与缓解/低疾病活动度存在的关联并进行调整。

主要发现

  • 共纳入431例患者(女性49.3%),其中136例(31.6%)为肥胖。
  • 肥胖患者较非肥胖患者年龄更大、女性更多、压痛关节数和附着点炎计数更高,疼痛、躯体功能和健康相关生活质量更差。
  • 肥胖患者达到VLDA的调整OR为0.31(95%CI 0.13-0.77),达到DAPSA缓解的调整OR为0.39(95%CI 0.19-0.80),达到MDA的调整OR为0.61(95%CI 0.38-0.99)。
  • DAPSA-LDA和患者报告的缓解/低疾病活动度率在肥胖与非肥胖患者中相似。

关键数值与推荐

  • 缓解/低疾病活动度定义为极低疾病活动度(VLDA)/最低疾病活动度(MDA)、银屑病关节炎疾病活动度(DAPSA)≤4/≤14,或基于患者意见。
  • 肥胖定义为医生报告和/或体重指数≥30 kg/m2。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to evaluate whether obese patients with psoriatic arthritis (PsA) were less likely to be in remission/low disease activity (LDA). METHODS: We used data from the ReFlaP, an international multi-centre cohort study (NCT03119805), which recruited consecutive adults with definite PsA (disease duration ≥ 2 years) from 14 countries. Demographics, clinical data, comorbidities, and patient-reported outcomes were collected. Remission/LDA was defined as Very Low Disease Activity (VLDA)/minimal disease activity (MDA), Disease Activity in PSoriatic Arthritis (DAPSA) ≤4/≤14, or by patients' opinion. Obesity was defined as physician-reported and/or body mass index ≥30 kg/m2. We evaluated the association between obesity and the presence of remission/LDA, with adjustment in multivariable regression models. RESULTS: Among 431 patients (49.3% women), 136 (31.6%) were obese. Obese versus non-obese patients were older, more frequently women, had higher tender joint and enthesitis counts and worse pain, physical function and health-related quality of life. Obese patients were less likely to be in VLDA; DAPSA remission and MDA, with adjusted ORs of 0.31 (95% CI 0.13 to 0.77); 0.39 (95% CI 0.19 to 0.80) and 0.61 (95% CI 0.38 to 0.99), respectively. Rates of DAPSA-LDA and patient-reported remission/LDA were similar for obese and non-obese patients. CONCLUSION: PsA patients with comorbid obesity were 2.5-3 folds less likely to be in remission/LDA by composite scores compared with non-obese patients; however, remission/LDA rates were similar based on the patients' opinion. PsA patients with comorbid obesity may have different disease profiles and require individualised management.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Leung YY, Eder L, Orbai AM, et al. Association between obesity and likelihood of remission or low disease activity status in psoriatic arthritis applying index-based and patient-based definitions of remission: a cross-sectional study. RMD Open. 2023. PMID: 37709527. doi:10.1136/rmdopen-2023-003157

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。